VACCINE FORMULATIONS FOR LEISHMANIA

摘要

The present invention involves the use of Leishmania antigens and nucleic acids coding therefor as vaccines. It also provides a method of inducing protective immune responses in a subject through the use of specific delivery systems such as protein and/or DNA vaccines and Listeria monocytogenes vectors.